The Wisconsin Alzheimer’s Disease Research Center supports researchers in their pursuit of answers that will lead to improved diagnosis and care for patients while, at the same time, focusing on the program’s long-term goal — finding a way to prevent and effectively treat Alzheimer’s disease.

Learn more

Recent News

Drs. Art Walaszek, Cynthia Carlsson, Shenikqua Bouges, and Jack Temple sit around a table talking on stage at the 2023 Fall Community Conversation
Over 300 guests attended the Fall Community Conversation on September 21, 2023, held at the Middleton Performing Arts Center in Middleton, WI.
Art Walaszek, MD, stands behind a podium to talk to a crowd. The WORT-FM logo and Fall Community Conversation logo appear to the left of the podium
Dr. Walaszek chatted with host Jan Miyasaki about what new treatments are available, what the annual event will focus on and how ageism impacts society’s views on aging.
Dr. Sterling Johnson in front of a screen with multiple PET scans and MRI scans. He points on the right side of the screen, where the Wisconsin Public Radio logo has been edited on top of the screen
Sterling Johnson, PhD, discussed strategies to prevent Alzheimer’s disease and the research being done by the Wisconsin Registry for Alzheimer’s Prevention (WRAP) on Wisconsin Public Radio (WPR).
Red background, white puzzle of a brain with a piece missing in foreground, Wisconsin ADRC logo to the left
Lifestyle and chronic health conditions in middle age, along with a person’s education level, show associations with emerging blood markers of neurodegeneration and Alzheimer's disease.
A group of researchers from the Wisconsin Alzheimer's Disease Research Center (ADRC) surrounding a sign for #AAIC23 at the Alzheimer's Association International Conference in July 2023
More than 50 students and faculty from the University of Wisconsin–Madison participated and presented at the 2023 Alzheimer’s Association International Conference (AAIC) in Amsterdam, Netherlands.
Nathaniel Chin, MD, at his desk with the Wisconsin Public Radio logo on his computer
Nathaniel Chin, MD, joined WPR's Central Time and The Morning Show to discuss the FDA's full approval of Leqembi (lecanemab-Irmb) and dementia care.